Berry Calls for Hearings on FDA, Vioxx

NOVEMBER 30, 2004 - Posted at 5:31 p.m. CST

WASHINGTON, DC - First District Congressman Marion Berry wrote to Congressional leaders today requesting the Energy and Commerce Committee hold a hearing on the Food & Drug Administration's (FDA) handling of the Vioxx safety issue.

The letter was addressed to House Speaker Dennis Hastert, Majority Leader Tom DeLay, Chairman of the Energy and Commerce Committee Joe Barton and others.

"When the federal agency charged with protecting the safety of our drug supply does not conduct long-term safety issues we need to ask why," Berry said.  "There is evidence of potentially disreputable negotiations between the company that makes Vioxx and the FDA at the expense of millions of patients.  I would expect both the company and the FDA would want an opportunity to clarify these serious allegations."